Myeloid growth factors

J Natl Compr Canc Netw. 2009 Jan;7(1):64-83. doi: 10.6004/jnccn.2009.0006.
No abstract available

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Decision Trees
  • Drug Administration Schedule
  • Fever / chemically induced
  • Fever / drug therapy*
  • Fever / prevention & control
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage
  • Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Neutropenia / chemically induced
  • Neutropenia / drug therapy*
  • Neutropenia / prevention & control
  • Patient Selection
  • Polyethylene Glycols
  • Recombinant Proteins
  • Risk Assessment
  • United States

Substances

  • Antineoplastic Agents
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • pegfilgrastim
  • Polyethylene Glycols
  • sargramostim
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Filgrastim